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Abstract
Background: DNA methylation has been widely used in classification, early diagnosis, therapy and prediction of
metastasis as well as recurrence of cervical cancer. DNMT methyltransferase 1 (DNMT1), which plays a significant
role in maintaining DNA methylation status and regulating the expression of tumor suppressor genes. The aim of
this research was to investigate the relationship between DNMT1 and abnormal methylation of tumor suppressor
genes and malignant phenotype in cervical cancer.
Methods: Levels of DNMT1 mRNA and protein were detected using qPCR and Western blot, respectively. Cell
proliferation was analyzed by MTT and apoptosis was performed by Annexin V-FITC/PI double staining flow
cytometry, respectively. MeDIP-qPCR and qPCR were performed to measure demethylation status and mRNA re-
expression level of 7 tumor-suppressor genes (CCNA1, CHFR, FHIT, PAX1, PTEN, SFRP4, TSLC1) in Hela and Siha cells
after silencing DNMT1.
Results: The average expression levels of DNMT1 mRNA and protein in Hela and Siha cells were decreased
significantly compared with control group. The flow cytometry and MTT results showed that Hela and Siha cells
apoptosis rates and cell viabilities were 19.4 ± 2.90%, 25.7 ± 3.92% as well as 86.7 ± 3.12%, 84.16 ± 2.67%
respectively 48 h after transfection (P < 0.01). Furthermore, the promoter methylation of five tumor suppressor
genes was decreased with the increased mRNA expression after silencing DNMT1, whereas there were no
significant changes in PTEN and FHIT genes in Hela cells, and CHFR and FHIT genes in Siha cells.
Conclusions: Our experimental results demonstrate that methylation status of DNMT1 can influence several
important tumor suppressor genes activity in cervical tumorigenesis and may have the potential to become an
effective target for treatment of cervical cancer.
Background
Cervical cancer is the second most common cancer in
women worldwide and the leading cause of cancer deaths
in women in developing countries. It is obviously that
many genetic and epigenetic alternations occur during
cervical tumorigenesis. Among those changes, aberrant
promoter methylation of tumor-suppressor genes gives
rise to its silencing functions and results in the significant
carcinogenesis of cervical cancer.
Currently, the known repressor genes are related to cer-
vical cancer including CCNA1, CHFR, FHIT, PAX1,
PTEN, SFRP4, TSLC1 and etc [1]. All these genes men-
tioned above have performed a wide variety of functions to
regulate the transcription and expression, any of which
down-regulation as well as promoter hypermethylation will
lead to the precursor lesions in cervical development and
malignant transformation. DNA methylation is catalyzed
by several DNA methyltransferases, including DNMT1,
DNMT3a, DNMT3b and etc. DNMT1 is responsible for
precise duplicating and maintaining the pre-existing DNA
methylation patterns after replication. As reported by Szyf
[2], DNMT1 inhibited the transcription of tumor suppres-
sor genes and facilitated the formation of tumorigenesis,
which linked to the development of cervical cancer.
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hypermethylation of repressive genes and promote its re-
expression, and reverse phenotype of malignant tumor.
Thus, specific inhibition of DNMT1 could be one strategy
for cervical therapy.
In our study, we detected the demethylation and re-
expression levels of seven cervical cancer suppressor genes
with DNMT1 silencing in Hela and Siha cells. The aim
was to elucidate the relations between DNMT1 and
abnormal methylation of these genes’ promoter as well as
the malignant phenotype of tumor cells, which might con-
tribute to the investigations of functions and regulation
roles of DNMT1 in cervical cancer.
Materials and methods
Cell culture and transfection
The Hela and Siha human cervical cancer cells lines were
obtained from American Type Culture Collection (Mana-
ssas, VA, USA). Lipofectamine TM2000 was purchased
from Invitrogen Co. These cells grown in Dulbeco’sM o d i -
fied Eagle Medium (DMEM) supplemented with 10% fetal
bovine serum and incubated at 37°C in a humidified
chamber with 5% CO2. The siRNA primer sequences for
DNMT1 were 5’-UUAUGUUGCUCACAAACUUCUU-
GUC-3’ (forward) and 5’-GACAAGAAG UUUGUGAG-
CAACAUAA-3’ (reverse), which were custom synthesized
by Shanghai Sangon (Shanghai, China). After transfection,
the inhibition efficiency was examined using quantitative
polymerase chain reaction (qPCR). Transfections were
performed with Lipfectamine TM2000 according to the
protocol (Invitrogen Co.).
Real-time qPCR assay
QPCR was used to analyze mRNA expression level
of DNMT1. Total RNA was extracted using Trizol
reagent and reversely transcribed into cDNA. The primers
for DNMT1 were 5’-AACCTTCACCTAGCCCCAG-3’
(forward) and 5’-CTCATCCGATTTGGCTCTTCA-
3’(reverse); for GAPDH were 5’-CAGCCTCAAGATCAT-
CAGCA-3’(forward) and 5’-TGTGGTCATGAGTCC
TTCCA-3’ (reverse). QPCR was performed in a 20 μl
volume containing 1 μl cDNA template, 10 μlS Y B R
Green Real-time PCR Master Mix and 1 μl of each primer.
Levels of seven tumor suppressor genes mRNA expression
were also assayed with qPCR. This cycle was defined at
95°C for 5 min, followed by 35 cycles of denaturing at
95°C for 45s, annealing at 59°C for 35 s and extension at
72°C for 1 min, and followed by the final extension at
72°C for 10 min. The primers were shown in Table 1 and
Table 2.
Western blot analysis
Cells were harvested and rinsed twice in ice-cold PBS,
and kept on ice for 30 min in cell lysis buffer containing
1 mM PMSF while agitating constantly, and insoluble
cell debris was discarded by centrifugation for 10 min at
12,000 rpm at 4°C. The protein samples were separated
with 12% SDS-PAGE and subsequently transferred to
PVDF membranes (Millipore). Membranes were blocked
with 5% nonfat dry milk solution either at room tem-
perature for 2 h, and incubated with Rabbit anti-
DNMT1 and secondary antibody at 37°C for 2 h respec-
tively. The Membranes were stained with an enhanced
chemiluminescence solution. Band intensities are nor-
malized to b-actin as a loading control.
Annexin V-FITC/PI staining and flow cytometry
Cell cycle analysis: Cells were digested by typsin (0.25%)
and fixed with cold 70% ethanol at 48 h after transfec-
tion. After washed in phosphate-buffered saline, samples
were incubated with 100 μl RNase A at 37°C for 30 min
and stained with 400 μl propidium iodide (Sigma). Flow
Table 1 Primers used in RNA expression
gene Sequences Tm (°C) Product Size(bp)
QPCR GAPDH F:5’GGGAAACTGTGGCGTGAT3’
R:5’GAGTGGGTGTCGCTGTTGA3’
59 299
FHIT F:5’GGAGATCAGAGGAGGAAATGG3’
R:5’GGGAGTTGGAGTGACCGAG3’
59 233
PTEN F:5’ACACGACGGGAAGACAAGTT3’
R:5’CTGGTCCTGGTATGAAGAATG3’
59 157
CHFR F:5’GCGTAGAAATGCCCAAACC3’
R:5’TCCATCCAGCCCGAGTAGC3’
59 171
SFRP4 F:5’GGCCTCTTGATGTTGACTGTAA3’
R:5’GAGGGATGGGTGATGAGGA3’
59 204
PAX1 F:5’GGTAGGAGTAGGGAGCACAGG3’
R:5’CAAGTGTTGCGAGTGGAGG3’
59 100
TSLC1 F:5’TTATTTCAGGGACTTCAGGC3’
R:5’TTCCACCGCAGTGTCTTTC3’
59 223
CCNA1 F:5’GCCTGGCAAACTATACTGTGAAC3’
R:5’GTGCAGAAGCCTATGACGATTA3’
59 295
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mine the DNA contents.
Apoptosis analysis: Cells were harvested as described
above. After adding of 10 μl Binding reagent and 1.25 μl
Annexin V-FITC, samples were suspended in 0.5 ml cold
1 × Binding Buffer and stained with 10 μl PI. The samples
were then analyzed for apoptosis by flow cytometry.
MTT assay
Cellular proliferation was measured using MTT assay. 10
4
cells were seeded in 96-well plates and cultured with
siRNA-DNMT1 at 37°C in a humid chamber with 5%
CO2 for 24 h. 50 μl 1 × MTT was then added to each well
and incubated with cells at 37°C for 4 h. After removal of
supernatant, 150 μl DMSO were added to each well. The
optical density (OD) was measured at 550 nm. The per-
centage of viability was calculated according to the follow-
ing formula: viability% = T/C×100%, where T and C refer
to the absorbance of transfection group and cell control,
respectively.
MeDIP-qPCR assay
Transfections were performed as described above. MeDIP
assay combined with qPCR were used to quantitatively
assess the status of demethylation. Hela and Siha cells
were transfected with siRNA and treated with 1.0 μM5 -
az-dC (Sigma) respectively, and harvested at 72 h after
incubation. Genomic DNA was extracted and randomly
sheared to an average length of 0.2-1.0 kb by sonication.
Dilution buffer and 60 μl Protein G Magnetic Bead sus-
pension were added into the fragmented DNA and
allowed for more than 10 min of incubation. DNA was
then incubated overnight at 4°C with 8 μg antibody (Epi-
gentek) against 5-methylcytosine, followed by 2 h incuba-
tion with Mouse-IgG magnetic beads at 4°C. The
methylated DNA/antibody complexes were then washed
with 1 ml cold WB1, WB2 and WB3 buffer. Purified DNA
was analyzed by qPCR on an Applied Biosystems 7500
Real-Time PCR System. Real-time PCR was performed in
a total 8 μl volume containing 1 μl of DNA template, 5 μl
of 2 × Master Mix, 1 μld d H 2Oa n d1μl of each primer.
The relative changes in the extent of promoter methyla-
tion were determined by measuring the amount of promo-
ter in immunoprecipitated DNA after normalization to the
input DNA: %(MeDNA-IP/Input) = 2^[(Ct(input)-Ct
(MeDNA-IP)×100.
Statistic analysis
Statistical analyses were performed with SPSS version
13.0(SPSS, Chicago, USA). Quantitative results were
given as mean ± SD and statistical analysis was carried
out by t-test. P values less than 0.05 were considered as
statistically significant.
Results
Effects of siRNA on DNMT1 mRNA and protein level
QPCR and western blot were performed to analyze the
mRNA and protein expression levels of DNMT1 in Hela
and Siha cells at 72 h after transfection. As shown in
Figure 1A, Hela and Siha cells transfected with DNMT1-
siRNA (transfection group) displayed lower level of
mRNA expression (P < 0.01), with inhibitory ratios of
56.21% and 41.31% respectively compared with control
group (negative siRNA). No significant change in DNMT1
mRNA expression was found between control group and
blank control (Lipo 2000). The transcript quantity of
GAPDH in transfection group, control group and blank
control did not change significantly. Figure 1B showed the
DNMT1 protein expression levels in Hela and Siha cells at
72 h after transfected with DNMT1-siRNA. The protein
level of DNMT1 decreased significantly compared with
control group and blank control (P < 0.01). The inhibitory
ratios of DNMT1 protein level in Hela and Siha cells were
50.31% and 99.76%, respectively.
Table 2 Primers used in MeDIP-qPCR assay
gene Sequences Tm (°C) Product Size(bp)
MSP FHIT F:5’GAAAGCCATAGTGACAGTAACCC3’
R:5’AAAGCCAAAGATTGTGCGATT3’
59 121
CCNA1 F:5’CTCCCGAGCCAGGGTTCT3’
R:5’CGTTCTCCCAACAGCCGC3’
59 76
PTEN F:5’GAGCGAATGCAGTCCACG3’
R:5’AGGCAGGGTAGGCTGTTGT3’
59 232
CHFR F:5’TTGCCTCAGTATCTCACTTCTT3’
R:5’TCGCCGTCTTTACTCCTCT3’
59 118
SFRP4 F:5’CCCCATTCTTTCCCACCTC3’
R:5’TCGCCTGAAGCCATCGTC3’
59 164
PAX1 F:5’AGGAGACCCTGGCATCTTTG3’
R:5’GACGGCGGCTGCTTACTT3’
59 168
TSLC1 F:5’GGGAGAACGGCGAGTTTAG3’
R:5’GGCTGAGGGCATCTGTGAG3’
59 215
Zhang et al. Journal of Experimental & Clinical Cancer Research 2011, 30:98
http://www.jeccr.com/content/30/1/98
Page 3 of 8Effects of DNMT1 silencing on cell cycle and apoptosis
The G0/G1 ratio (74.72 ± 3.17%) of Hela cells in trans-
f e c t i o ng r o u pw a sh i g h e rt h a nt h a ti nc o n t r o lg r o u p
(65.88 ± 3.23%) (P < 0.01), and cells at S phase were
fewer compared with control group. Meanwhile, The
G0/G1 ratio (76.43 ± 2.20%) of Siha cells in transfection
group displayed significantly higher compared with con-
trol group (66.4 ± 1.99%) (P < 0.01), while cells at S
phase were fewer than those in control group. No signif-
icant changes in G0/G1 ratio or cells at S phase were
detected between the control group and blank control
(Figure 2A). Furthermore, as shown in Figure 2B, the
apoptosis of Hela cells in transfection group was signifi-
cantly higher than that in control group (P < 0.01).
Similar results were observed in Siha cells.
Effects of DNMT1 silencing on cell growth and
proliferation
Cell growth and proliferation of Hela and Siha cells were
examined using MTT assay. As shown in Figure 3, viabil-
ities of Hela cells in transfection group were 91.47%,
86.74%, 78.92% and 48.98% at 24, 48, 72 and 96 h, respec-
tively (P < 0.05) compared with control group at each time
point. We observed the similar results in Siha cells with
viabilities of 90.45%, 84.16%, 71.09% and 60.47% at 24, 48,
72 and 96 h after transfection, respectively (P < 0.05) com-
pared with control group at each time point.
Effects of DNMT1 silencing on gene demethylation and
mRNA expression level in Hela cell
Methylation status and mRNA expression level of seven
repressive genes in Hela cells were performed with
MeDIP-qPCR assay and Real-time PCR (Figure 4) com-
pared with drug group(5-aza-dC, methylase inhibitors),
control group and blank group. Specifically, PAX1,
SFRP4 and TSLC1 possessed higher levels of methyla-
tion, while CHFR and FHIT were relatively lower.
Except for FHIT and PTEN, the rest five suppressor
genes CCNA1, CHFR, PAX1, SFRP4 and TSLC1 in
transfection group displayed lower level of methylation
status compared with control group (P< 0.01), which
decreased to 34.42%, 15.57%, 22.36%, 52.09% and
35.53%, respectively. The effects of DNMT1-siRNA and
5-aza-dC treatment were performed the identical phe-
nomenon. The relative mRNA levels of seven repressive
genes were detected by Real-time PCR. It’sc l e a rt h a t
the expression of PTEN was higher than other genes.
Except for FHIT and PTEN, the expression levels of
CCNA1, CHFR, PAX1, SFRP4 and TSLC1 in transfec-
tion group were higher than those in control group,
Figure 1 Effects of siRNA on DNMT1 mRNA and protein expression.( A ) :m R N Ae x p r e s s i o nl e v e l so fD N M T 1i nH e l aa n dS i h ac e l l sw e r e
examined by qPCR. Compared with control group, Hela and Siha cells transfected with DNMT1-siRNA displayed lower level of mRNA expression
(**P < 0.01). (B): DNMT1 protein levels in Hela and Siha cells were determined by western blot. The protein level of DNMT1 decreased
significantly compared with control group and blank control. (1: transfection group (DNMT1-siRNA); 2: control group (negative siRNA); 3: blank
group (Lipo2000), n = 3).
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Page 4 of 8Figure 2 Effects of DNMT1 silencing on cell cycle and apoptosis. (A): Phases of cell cycle of Hela and Siha cells were analyzed by flow
cytometry assay at 48 h after transfection (**P < 0.01). (B): Apoptosis of Hela and Siha cells was analyzed by flow cytometry assay at 48 h after
transfection (**P < 0.01). (1: transfection group (DNMT1-siRNA); 2: control group (negative siRNA); 3: blank group (Lipo2000), n = 3).
Figure 3 Viability of Hela and Siha cells at different time after transfection determined by MTT assay. Viabilities of Hela and Siha cells in
transfection group were 91.47%, 86.74%, 78.92%, 48.98% and 90.45%, 84.16%, 71.09%, 60.47% at 24, 48, 72 and 96 h, respectively. (n = 3, *P <
0.05, **P < 0.01, compared with control group).
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4.87 and 3.51 folds, respectively.
Effects of DNMT1 silencing on gene demethylation and
mRNA expression level in Siha cell
Figure 5 showed the methylation status and mRNA levels
in Siha cells were similar to those in Hell cells. PAX1,
SFRP4 and TSLC1 possessed higher level of methylation
status, while PTEN and FHIT were relatively lower.
Except for FHIT and CHFR, the rest five repressor genes
CCNA1, PAX1, PTEN, SFRP4 and TSLC1 in transfection
group displayed lower level of methylation compared
with control group (P< 0.01), which decreased to 35.21%,
23.75%, 19.51%, 33.15% and 38.04%, respectively.
Furthermore, the relative mRNA expression level of
PTEN was higher than other genes. Except for FHIT and
CHFR, the mRNA expression levels of CCNA1, PAX1,
PTEN, SFRP4 and TSLC1 in transfection group were
higher than those in control group, with relative mRNA
levels increased 7.22, 2.88, 2.32, 7.04 and 3.47 folds,
respectively.
Discussion
DNMT1 silencing in cervical cancer cells could induce
re-expression of most tumor suppressor genes by
demethylating its promoter region, and co-silencing of
DNMT1 and DNMT3b might perform a greater inhibi-
tory effect on tumorigenesis [3]. Sowinska [4] demon-
s t r a t e dt h a tc o m b i n e dD N M T 1a n dD N M T 3 bs i R N A s
could enhance promoter demethylation and re-expres-
sion of CXCL12 in MCF-7 breast cancer as well as
AsPC1 in pancreatic carcinoma cell lines, and suggested
that they acted synergistically in inhibiting CpG island
hypermethylation of tumor suppressor genes. Rhee et al
Figure 4 Effects of DNMT1 silencing on gene methylation and mRNA expression of seven tumor suppressor genes in Hela cells
assayed by MeDIP combined with Real-Time PCR. Except for FHIT and PTEN, the rest five suppressor genes CCNA1, CHFR, PAX1, SFRP4 and
TSLC1 in transfected group displayed lower level of methylation with increased mRNA expression when compared with control group. (n = 3,
**P < 0.01).
Figure 5 Effects of DNMT1 silencing on gene methylation and mRNA expression of seven tumor suppressor genes in Siha cells
assayed by MeDIP combined with Real-Time PCR. Except for FHIT and CHFR, the rest five suppressor genes CCNA1, PTEN, PAX1, SFRP4 and
TSLC1 in transfected group displayed lower level of methylation with increased mRNA expression when compared with control group. (n = 3,
**P < 0.01).
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cer cell line reduced global DNA methylation by less
than 3%, but co-silencing of both DNMT1 and DNMT3b
nearly eliminated methyltransferase activity, and reduced
genomic DNA methylation by greater than 95%. Thus,
DNMT1 and DNMT3b play the significant role in pro-
moter methylation of tumor suppressor genes and
tumorigenesis in its early status. Currently, functions and
mechanisms of DNMTs in cervical cancer cells remained
unclear, and whether DNMT1 and DNMT3b act syner-
gistically or through other ways exploration efforts were
still required study.
In human bladder cancer cells, selective depletion of
DNMT1 with siRNA induced demethylation and reactiva-
tion of the silenced tumor-suppressor gene CDKN2A [6].
RNAi-mediated knockdown of DNMT1 resulted in signifi-
cant reduction of promoter methylation and re-expression
of RASSF1A, p16, and HPP1 in HCC1954 breast cancer
cells [7]. In ovarian cancer cell line CP70, DNMT1 siRNA
treatment led to a partial removal of DNA methylation
f r o mt h r e ei n a c t i v ep r o m o t e rC p Gi s l a n d s ,T W I S T ,
RASSF1A, and HIN-1, and restored the expression of
these genes [8]. Thus, RNAi-mediated DNMT1 depletion
in different tumor cells could induce demethylation of var-
ious tumor suppressor genes and enhance re-expression.
However, contradictory results were reported even in the
same cell line. Ting et al [9] found that hypermethylation
of CDKN2A, SFPR1, GATA4 and GATA5 were still main-
tained in HCT116 colorectal cancer cells after transiently
or stably depleted of DNMT1, and suggested that
DNMT1 might not play the dominant effect which caused
hypermethylation of CpG islands in tumor suppressor
genes. Knockout of DNMT1 in HCT116 cells by homolo-
gous recombination only reduced global DNA methylation
by 20% and p16 maintained completely methylated status.
Besides, methylations of HMLH1, p16 and CDH1 in gas-
tric-cancer tissue samples at different progress periods do
not correlate with the expression of DNMT1 directly [10].
Therefore, whether over-expression of DNMT1 accounts
for the only or key causes of hypermethylation of tumor
suppressor genes remains to be confirmed.
Currently, correlation between methlylation and mRNA
expression still remains unclear. In our study, methylation
status of five suppressor genes (such as PAX1) in transfec-
tion group was significantly lower than that in control
group or blank control, and the mRNA expression levels
were higher as compared to the two types of control, sug-
gesting that lower level of methylation facilitates mRNA
expression. This trend was confirmed when CCNA1,
SFRP4, TSLC1 and CHFR in Hela cells and CCNA1,
PTEN, SFRP4 and TSLC1 in Siha cells were analyzed.
Surprisingly, transfection did not affect the methyla-
tion status and mRNA expression of FHIT and PTEN in
Hela cells and FHIT and CHFR in Siha cells in our
study, even though both of these two genes might
achieve high mRNA expression through low methyla-
tion. It was previously reported that there was no PTEN
mutation in 63 cases of squamous cervical carcinomas,
but 58% of the cases showed high methylation of PTEN
promoter [11,12]. Wu et al [13] reported that FHIT was
highly methylated in Hela, C33A and Siha cervical can-
cer cells, and that aberrant methylation of the FHIT
gene might be a key mechanism for cervical tumorigen-
esis, which could be reactivated and whose tumor sup-
pressing function could be restored by treatment of
demethylating agent. Banno et al [14] reported that cer-
vical smears showed aberrant methylation of CHFR in
12.3% of adenocarcinoma specimens, while aberrant
DNA methylation was not detected in normal cervical
cells. These researches demonstrated us that FHIT and
PTEN in Hela cells and FHIT and CHFR in Siha cells
might have the other regulation pathways for carcino-
genesis or transcription control, and which needs more
tests of cervical cancer cells and clinical specimens.
Apart from DNMT1 silencing, we treated Hela and
Siha cells with 5-aza-dC, which revealed the similar
results with transfection group. Five repressor genes
were demethylated to various degrees and the mRNA
expressions were also increased. These results are in
accordance with the findings of other reports [15-19],
which could be important in the development of new
and effective strategy in cervical treatment.
Conclusions
In conclusion, our study demonstrates that DNMT1
silencing could suppress proliferation and induce apop-
tosis of Hela and Siha cells. DNMT1-siRNA induces
demethylation of five tumor suppressor genes, including
CCNA1, CHFR, PAX1, SFRP4 and TSLC1 in Hela cells
and CCNA1, PTEN, PAX1, SFRP4 and TSLC1 in Siha
cells, and enhances their mRNA expression. In a word,
DNMT1 represents an important potential diagnostic
and therapeutic target for cervical cancer.
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